Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer mortality. CA19.9, the only tumor marker available to detect and monitor PDAC, is not sufficiently sensitive and specific to consistently differentiate early cancer from benign disease. In this study we aimed to valida...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Chan, Alison, Prassas, Ioannis, Dimitromanolakis, Apostolos, Brand, Randall, Serra, Stefano, Diamandis, Eleftherios P., Blasutig, Ivan M.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4233184/
https://ncbi.nlm.nih.gov/pubmed/25239611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0289
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker